• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与风湿性心脏病发病机制相关的信号通路(综述)

Signalling pathways implicated in the pathogenesis of rheumatic heart disease (Review).

作者信息

Xian Shenglin, Zeng Zhiyu

机构信息

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.

Guangxi Key Laboratory of Precision Medicine in Cardio-cerebrovascular Disease Control and Prevention and Guangxi Clinical Research Center for Cardio-cerebrovascular Diseases, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.

出版信息

Exp Ther Med. 2021 Jan;21(1):76. doi: 10.3892/etm.2020.9508. Epub 2020 Nov 25.

DOI:10.3892/etm.2020.9508
PMID:33365076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7716644/
Abstract

Rheumatic heart disease (RHD) is frequently encountered in underdeveloped areas and primarily affects patients under the age of 40 years old. The pathogenesis of RHD has yet to be fully elucidated and surgical treatment remains the only option, which is expensive and technically demanding for patients in less developed areas. Signalling pathways are crucial for the occurrence and development of several diseases, and researchers worldwide have made progress in elucidating the signalling pathways associated with the pathogenesis of RHD. The aim of the present review was to discuss 6 signalling pathways implicated in the pathogenesis of RHD, summarize the methods and progress of these studies and propose future research directions. Important information on the pathogenesis of RHD according to the current progress of signalling pathway studies was also summarized, in the hope that this review may serve as a reference for future research on the signalling pathways involved in the pathogenesis of RHD.

摘要

风湿性心脏病(RHD)在欠发达地区屡见不鲜,主要影响40岁以下的患者。RHD的发病机制尚未完全阐明,手术治疗仍然是唯一的选择,而这对欠发达地区的患者来说费用高昂且技术要求高。信号通路对多种疾病的发生和发展至关重要,世界各地的研究人员在阐明与RHD发病机制相关的信号通路上取得了进展。本综述的目的是讨论与RHD发病机制相关的6条信号通路,总结这些研究的方法和进展,并提出未来的研究方向。还根据信号通路研究的当前进展总结了RHD发病机制的重要信息,希望本综述可为未来RHD发病机制相关信号通路的研究提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b3d/7716644/0a4233218575/etm-21-01-09508-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b3d/7716644/0a4233218575/etm-21-01-09508-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b3d/7716644/0a4233218575/etm-21-01-09508-g00.jpg

相似文献

1
Signalling pathways implicated in the pathogenesis of rheumatic heart disease (Review).与风湿性心脏病发病机制相关的信号通路(综述)
Exp Ther Med. 2021 Jan;21(1):76. doi: 10.3892/etm.2020.9508. Epub 2020 Nov 25.
2
Methods for Establishing a Rat Model of Rheumatic Heart Disease.建立风湿性心脏病大鼠模型的方法。
Rev Cardiovasc Med. 2024 Sep 24;25(9):346. doi: 10.31083/j.rcm2509346. eCollection 2024 Sep.
3
Rheumatic heart disease: A review of the current status of global research activity.风湿性心脏病:全球研究活动现状综述。
Autoimmun Rev. 2021 Feb;20(2):102740. doi: 10.1016/j.autrev.2020.102740. Epub 2020 Dec 14.
4
An immunological perspective on rheumatic heart disease pathogenesis: more questions than answers.风湿性心脏病发病机制的免疫学观点:问题多于答案。
Heart. 2016 Oct 1;102(19):1527-32. doi: 10.1136/heartjnl-2015-309188. Epub 2016 Jun 3.
5
T cell subsets: an integral component in pathogenesis of rheumatic heart disease.T 细胞亚群:风湿性心脏病发病机制中的一个重要组成部分。
Immunol Res. 2018 Feb;66(1):18-30. doi: 10.1007/s12026-017-8978-z.
6
Interleukin-10: Role in increasing susceptibility and pathogenesis of rheumatic fever/rheumatic heart disease.白细胞介素-10:在增加风湿热/风湿性心脏病易感性和发病机制中的作用。
Cytokine. 2017 Feb;90:169-176. doi: 10.1016/j.cyto.2016.11.010. Epub 2016 Dec 3.
7
Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel.风湿性心脏病全球:JACC 科学专家小组。
J Am Coll Cardiol. 2018 Sep 18;72(12):1397-1416. doi: 10.1016/j.jacc.2018.06.063.
8
Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer?在发展中国家控制急性风湿热和风湿性心脏病:我们正在接近目标吗?
Curr Opin Pediatr. 2015 Feb;27(1):116-23. doi: 10.1097/MOP.0000000000000164.
9
Rheumatic fever and rheumatic heart disease: Facts and research progress in Africa.风湿热和风湿性心脏病:非洲的事实与研究进展。
Int J Cardiol. 2019 Nov 15;295:48-55. doi: 10.1016/j.ijcard.2019.07.079. Epub 2019 Jul 29.
10
Rheumatic fever and rheumatic heart disease: genetics and pathogenesis.风湿热与风湿性心脏病:遗传学与发病机制
Scand J Immunol. 2007 Aug-Sep;66(2-3):199-207. doi: 10.1111/j.1365-3083.2007.01974.x.

引用本文的文献

1
Study on the expression of lncRNA in oral squamous cell carcinoma.口腔鳞状细胞癌中长链非编码RNA的表达研究
Transl Cancer Res. 2024 Oct 31;13(10):5202-5213. doi: 10.21037/tcr-24-467. Epub 2024 Oct 29.
2
Correlation between circulating fibrosis biomarkers with left atrial function and left atrial volume index in rheumatic mitral stenosis.风湿性二尖瓣狭窄患者循环纤维化生物标志物与左心房功能和左心房容积指数的相关性。
Narra J. 2024 Apr;4(1):e293. doi: 10.52225/narra.v4i1.293. Epub 2024 Jan 8.
3
Detection and management of latent rheumatic heart disease: a narrative review.

本文引用的文献

1
CD4 T cells and TGFβ1/MAPK signal pathway involved in the valvular hyperblastosis and fibrosis in patients with rheumatic heart disease.CD4 T 细胞及 TGFβ1/MAPK 信号通路与风湿性心脏病患者瓣膜组织的过度增生和纤维化相关。
Exp Mol Pathol. 2020 Jun;114:104402. doi: 10.1016/j.yexmp.2020.104402. Epub 2020 Feb 13.
2
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity.靶向癌症中的 MAPK 信号通路:药物耐药性和敏感性的机制。
Int J Mol Sci. 2020 Feb 7;21(3):1102. doi: 10.3390/ijms21031102.
3
Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease.
潜伏性风湿性心脏病的检测与管理:一篇叙述性综述
Ann Med Surg (Lond). 2023 Oct 17;85(12):6048-6056. doi: 10.1097/MS9.0000000000001402. eCollection 2023 Dec.
4
The Immunomodulatory Role of Microbiota in Rheumatic Heart Disease: What Do We Know and What Can We Learn from Other Rheumatic Diseases?微生物群在风湿性心脏病中的免疫调节作用:我们知道什么以及能从其他风湿性疾病中学到什么?
Medicina (Kaunas). 2023 Sep 8;59(9):1629. doi: 10.3390/medicina59091629.
5
Effect of Dapagliflozin on Patients with Rheumatic Heart Disease Mitral Stenosis.达格列净对风湿性心脏病二尖瓣狭窄患者的影响。
J Clin Med. 2023 Sep 11;12(18):5898. doi: 10.3390/jcm12185898.
6
Coordination of PRKCA/PRKCA-AS1 interplay facilitates DNA methyltransferase 1 recruitment on DNA methylation to affect protein kinase C alpha transcription in mitral valve of rheumatic heart disease.协调 PRKCA/PRKCA-AS1 的相互作用有助于 DNA 甲基转移酶 1 募集到 DNA 甲基化,从而影响风湿性心脏病二尖瓣中蛋白激酶 Cα 的转录。
Bioengineered. 2021 Dec;12(1):5904-5915. doi: 10.1080/21655979.2021.1971482.
miR-155-5p 的抑制可减轻风湿性心脏病引起的瓣膜损伤。
Int J Mol Med. 2020 Feb;45(2):429-440. doi: 10.3892/ijmm.2019.4420. Epub 2019 Dec 6.
4
Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway.阿司匹林通过调节 JNK/STAT-3 信号通路抑制损伤肌腱愈合中的炎症和瘢痕形成。
Cell Prolif. 2019 Jul;52(4):e12650. doi: 10.1111/cpr.12650. Epub 2019 Jun 21.
5
STAT3: A Potential Drug Target for Tumor and Inflammation.STAT3:肿瘤和炎症的潜在药物靶点。
Curr Top Med Chem. 2019;19(15):1305-1317. doi: 10.2174/1568026619666190620145052.
6
Circulating cytokines predict severity of rheumatic heart disease.循环细胞因子可预测风湿性心脏病的严重程度。
Int J Cardiol. 2019 Aug 15;289:107-109. doi: 10.1016/j.ijcard.2019.04.063. Epub 2019 Apr 25.
7
Rheumatic heart disease in the modern era: recent developments and current challenges.现代风湿性心脏病:最新进展与当前挑战
Rev Soc Bras Med Trop. 2019 Mar 14;52:e20180041. doi: 10.1590/0037-8682-0041-2019.
8
Potential involvement of S1PR1/STAT3 signaling pathway in cardiac valve damage due to rheumatic heart disease.S1PR1/STAT3信号通路在风湿性心脏病所致心脏瓣膜损伤中的潜在作用。
Biotech Histochem. 2019 Aug;94(6):398-403. doi: 10.1080/10520295.2019.1574028. Epub 2019 Feb 4.
9
Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats.二甲双胍通过抑制 2 型糖尿病大鼠蛋白激酶 C/细胞外信号调节激酶信号通路调节心房 SK2 和 SK3 的表达。
BMC Cardiovasc Disord. 2018 Dec 13;18(1):236. doi: 10.1186/s12872-018-0950-x.
10
Extracellular Matrix for Myocardial Repair.细胞外基质在心肌修复中的作用。
Adv Exp Med Biol. 2018;1098:151-171. doi: 10.1007/978-3-319-97421-7_8.